The 2014 updated NICE guideline emphasizes individualized care and robust stroke and bleeding risk assessment before initiating oral anticoagulation for atrial fibrillation.
Answers are grounded in this paper and cite their sources.
Prioritizes individualized stroke/bleeding risk assessment before OAC in AF; extends prior guidelines toward patient-centered care.
There is significant progress made in the field of atrial fibrillation, especially regarding stroke stratification, novel pharmacological agents and interventions for improving symptom control. The Updated NICE Guideline for management of 2014 reflects that and provided an up-to-date appraisal regarding atrial fibrillation treatment, management with consideration to overall healthcare cost economics. It emphasizes the need for individualized, patient-centered package of care, and an robust stroke and bleeding risk before decision regarding choice of oral anticoagulation to be made.
No takes yet. Share an insight, caveat, or question.
Senoo et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: